Loading
A phase 1 trial of KSQ-4279 run by Hoffmann-La Roche, completed.
A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors is a phase 1 interventional study registered as NCT05240898 by Hoffmann-La Roche, with 116 participants enrolled, started 2021-08-26, primary completion reached 2025-11-26. Conditions recorded: Advanced Solid Tumors. Interventions recorded: RO7623066, Olaparib, Carboplatin.
Shares KSQ Therapeutics and the tag pipeline.
Shares KSQ Therapeutics and the tag pipeline.
Shares KSQ Therapeutics and the tag pipeline.
Shares KSQ Therapeutics and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/